Home

helps physicians and healthcare professionals

Erectile Dysfunction

helps physicians and healthcare professionals

Doctor123.org

helps physicians and healthcare professionals

Pneumonia, Adult, Emergency Medicine


Basics


Description


  • Epidemiology:
    • 7th leading cause of death and leading cause from infectious disease in US
  • Highest mortality in elderly and patients with the following coexisting conditions:
    • Chronic heart, lung, liver, and kidney disease
    • Diabetes mellitus
    • Alcoholism
    • Malignancy
    • Asplenia
    • Immunosuppression
    • Use of antimicrobials within last 3 mo
  • Classifications:
    • Source based:
      • Community acquired (CAP)
      • Health care associated (HCAP)
      • Hospital acquired (HAP)
      • Ventilator associated (VAP)
    • Symptom based:
      • Typical
      • Atypical
  • Complications:
    • Bacteremia
    • Sepsis
    • Abscess
    • Empyema
    • Respiratory failure

Etiology


  • CAP (typicals):
    • Streptococcus pneumoniae
    • Haemophilus influenzae
    • Klebsiella pneumoniae
    • Moraxella catarrhalis
    • Streptococcus pyogenes
    • Staphylococcus aureus
  • CAP (atypicals):
    • Mycoplasma pneumoniae
    • Chlamydophila pneumoniae
    • Legionella pneumophila
    • Viral
  • HCAP/HAP/VAP:
    • Gram negatives (Pseudomonas, Stenotrophomonas)
    • Methicillin-resistant S. aureus (MRSA)
  • Immunosuppressed:
    • Mycobacterium tuberculosis
    • Pneumocystis jirovecii
  • Aspiration:
    • Chemical pneumonitis ‚ ± oral and gastric anaerobes

Diagnosis


Signs and Symptoms


History
  • Typical:
    • Acute onset
    • Fever
    • Chills
    • Rigors
    • Cough
    • Purulent sputum
    • Shortness of breath
    • Pleuritic chest pain
  • Atypical:
    • Subacute onset
    • Viral prodrome
    • Nonproductive cough
    • Low-grade fever
    • Headache
    • Myalgias
    • Malaise
    • Absence of pleurisy and rigors

Physical Exam
  • Vital signs:
    • Tachypnea
    • Tachycardia
    • Hypoxia
    • Fever
  • Pulmonary exam:
    • Dullness to percussion
    • Tactile fremitus
    • Egophony
    • Rales
    • Rhonchi
    • Decreased breath sounds
  • Note that pneumonia may be present in the absence of the above signs of consolidation.

  • Elderly patients have higher morbidity and mortality from pneumonia.
  • Atypical presentations are more common.

Essential Workup


Combination of clinical and radiographic diagnosis ‚  

Diagnosis Tests & Interpretation


Lab
  • General:
    • CBC with differential
    • Serum chemistry
  • Others:
    • Blood cultures (ICU only)
    • Sputum cultures and Gram stain (ICU only)
    • Urine antigen tests for S. pneumoniae & Legionella
    • C-reactive protein possibly helpful
    • Lactate may be helpful
    • Influenza viral test

Imaging
Chest radiograph: ‚  
  • General:
    • Findings are nonspecific for particular infectious etiologies.
    • May be deferred in young, healthy patients receiving empiric outpatient management.
    • Negative imaging should not preclude antimicrobial therapy in patients with clinical diagnosis.
  • Suggestive findings:
    • Silhouette sign (R. heart border = RML, L. heart border = lingula, R. hemidiaphragm = RLL, L. hemidiaphragm = LLL)
    • Air bronchograms
    • Segmental or subsegmental consolidation
    • Diffuse interstitial opacities
    • Pleural effusion
    • Empyema
    • Abscess
    • Cavitation

Diagnostic Procedures/Surgery
Thoracentesis: ‚  
  • For large effusions, enigmatic pneumonia, and patients who fail to respond to standard therapy

Differential Diagnosis


  • Asthma
  • Bronchitis
  • CHF
  • COPD
  • Foreign-body aspiration
  • Occupational or environmental exposure
  • Pneumothorax
  • Pulmonary embolism
  • Tumor

Treatment


Pre-Hospital


  • IV access
  • Supplemental oxygen
  • Cardiac monitor
  • Consider inhaled bronchodilators.
  • Consider endotracheal intubation in cases of severe respiratory distress.

Initial Stabilization/Therapy


  • IV access and fluid resuscitation as needed
  • Supplemental oxygen
  • Cardiac monitor
  • Inhaled bronchodilators
  • Endotracheal intubation in cases of severe respiratory distress as indicated

Ed Treatment/Procedures


  • American Thoracic Society guidelines for empiric therapy:
  • Outpatient:
    • Previously healthy, no coexisting conditions:
      • Macrolide (azithromycin) OR doxycycline
    • Significant coexisting conditions (see above):
      • Combination Ž ˛-lactam (ceftriaxone, cefuroxime, cefpodoxime, high-dose amoxicillin, Augmentin) PLUS macrolide (azithromycin) OR
      • Respiratory floroquinolone (levofloxacin, moxifloxacin) alone
  • Inpatient:
    • Noncritical care:
      • Combination Ž ˛-lactam PLUS macrolide OR
      • Respiratory floroquinolone alone
    • Critical care:
      • Combination Ž ˛-lactam PLUS macrolide OR respiratory floroquinolone
      • For Pseudomonas, consider adding antipseudomonal agent (piperacillin/tazobactam, imipenem, meropenem, cefepime) PLUS antipseudomonal fluoroquinolone (high-dose levofloxacin) OR antipseudomonal agent (see above) PLUS aminoglycoside (gentamicin) PLUS macrolide (azithromycin).
      • For MRSA, consider adding vancomycin OR linezolid.
      • For aspiration, consider adding clindamycin OR metronidazole.
      • For drug-resistant S. pneumoniae, consider adding vancomycin.

Medication


  • Amoxicillin " “clavulanate (Augmentin): 500 mg PO q12h
  • Ampicillin " “sulbactam (Unasyn): 1.5 " “3 g IV q6h
  • Azithromycin: 500 mg PO on day 1 and 250 mg PO on days 2 " “5 OR 500 mg PO daily for 3 days OR 500 mg IV daily
  • Aztreonam: 1 " “2 g IV q12h
  • Cefepime: 2 g IV q12h
  • Cefotaxime: 1 " “2 g IV q8h
  • Cefpodoxime: 200 mg PO q12h
  • Ceftazidime: 2 g IV q12h
  • Ceftriaxone: 1 " “2 g IV daily
  • Cefuroxime: 0.75 and 1.5 g IV q8h
  • Doxycycline: 100 mg PO/IV q12h
  • Ertapenem: 1 g IV daily
  • Levofloxacin: 500 " “750 mg PO/IV daily
  • Linezolid: 600 mg PO/IV daily
  • Imipenem: 500 mg IV q6h
  • Meropenem: 1 g IV q8h
  • Moxifloxacin: 400 mg IV daily
  • Piperacillin " “tazobactam (Zosyn): 3.375 " “4.5 g IV q6h
  • Vancomycin: 1 g IV q12h

First Line
  • Outpatient:
    • Healthy:
      • Azithromycin 500 mg PO day 1, 250 mg PO days 2 " “5 OR 500 mg PO daily for 3 days
    • Comorbidities:
      • Levofloxacin 750 mg PO daily for 5 days
  • Inpatient:
    • Non-ICU:
      • Levofloxacin 750 mg IV daily
    • ICU:
      • Ceftriaxone 1 g IV daily AND levofloxacin 750 mg IV daily ‚ ± piperacillin " “tazobactam 4.5 g IV q6h ‚ ± vancomycin 1g IV q12h

Second Line
Aztreonam may be substituted for Ž ˛-lactams in confirmed penicillin-allergic patients for the above ICU regimens. ‚  

Follow-Up


Disposition


Admission Criteria
  • Based on severity of illness, coexisting conditions, ability of home care, and follow-up
  • Clinical decision-making rules may aid in stratifying patients but should not supersede clinical judgment.
  • CURB-65 rule:
    • Criteria:
      • Confusion (Abbreviated Mental Test ≤8)
      • Urea >7 mmol/L OR BUN >19
      • Respiratory rate ≥30/min
      • BP with SBP <90 mm Hg, DBP <60 mm Hg
      • Age ≥65 yr
    • Interpretation:
      • 0 " “1: Outpatient treatment
      • 2: Close outpatient vs. brief inpatient
      • 3 " “5: Inpatient with ICU consideration
  • Pneumonia Severity Index:
    • Demographics:
      • If Male: + age (yr)
      • If Female: + age (yr) " “ 10
      • If nursing home resident: +10
    • Comorbid illness:
      • Neoplastic disease: +30
      • Liver disease: +20
      • Congestive heart failure: +10
      • Cerebrovascular disease: +10
      • Renal disease: +10
    • Physical exam findings:
      • Altered mental status: +20
      • Pulse ≥125/min: +20
      • Respiratory rate >30/min: +20
      • SBP <90 mm Hg: +15
      • Temperature <35 ‚ °C or ≥40 ‚ °C: +10
    • Lab and radiographic findings:
      • Arterial pH < 7.35: +30
      • BUN ≥30 mg/dL: +20
      • Sodium <130 mmol/L: +20
      • Glucose ≥250 mg/dL: +10
      • Hematocrit <30%: +10
      • PaO2 <60 mm Hg: +10
      • Pleural effusion: +10
    • Interpretation:
      • 0: Class I (outpatient)
      • <70: Class II (outpatient vs. short observation)
      • 71 " “90: Class III (home with IV antibiotics vs. short observation)
      • 91 " “130: Class IV (inpatient)
      • >130: Class V (inpatient)
  • Additional considerations:
    • Previous hospitalization within last year for pneumonia
    • Failed outpatient therapy
    • Social conditions preventing safe outpatient disposition

Discharge Criteria
  • Age <65 yr
  • No comorbid illnesses
  • Nontoxic appearance
  • Normal vital signs
  • Normal lab studies
  • Primary care follow-up within 72 hr

Issues for Referral
Follow-up with primary care within 72 hr ‚  

Followup Recommendations


Primary care follow-up within 72 hr ‚  

Pearls and Pitfalls


  • Delayed initiation of antibiotics in ill-appearing patients
  • Failure to recognize pneumonia in patients assumed to have exacerbations of underlying lung conditions
  • Failure to question patients regarding TB and HIV risk factors
  • Elderly and immunocompromised patients may not exhibit any classic symptoms of pneumonia when ill.

Additional Reading


  • Mandell ‚  LA, Wunderink ‚  RG, Anzueto ‚  A, et al. Infectious Disease Society of America/American Thoracic Society consensus guidelines on the management of community-acquired pneumonia in adults. Clin Infect Dis.  2007;44(suppl 2):S27 " “S72.
  • Moran ‚  GJ, Talan ‚  DA. Pneumonia. In: Marx ‚  JA, Hockberger ‚  RS, Walls ‚  RM, et al., eds. Rosens Emergency Medicine: Concepts and Clinical Practice. 7th ed. St. Louis, MO: Mosby; 2009: 927 " “938.
  • Moran ‚  GJ, Talan ‚  DA, Abrahamian ‚  FM. Diagnosis and management of pneumonia in the emergency department. Infect Dis Clin North Am.  2008;22(1):53 " “72.
  • Nazarian ‚  DJ, Eddy ‚  OL, Lukens ‚  TW, et al. Clinical policy: Critical issues in the management of adult patients presenting to the emergency department with community-acquired pneumonia. Ann Emerg Med.  2009;54:704 " “731.

See Also (Topic, Algorithm, Electronic Media Element)


  • Pneumonia, Pediatric
  • Pneumocystis carinii Pneumonia

Codes


ICD9


  • 481 Pneumococcal pneumonia [Streptococcus pneumoniae pneumonia]
  • 486 Pneumonia, organism unspecified
  • 507.0 Pneumonitis due to inhalation of food or vomitus
  • 997.31 Ventilator associated pneumonia
  • 482.0 Pneumonia due to Klebsiella pneumoniae
  • 482.2 Pneumonia due to Hemophilus influenzae [H. influenzae]
  • 482.40 Pneumonia due to Staphylococcus, unspecified
  • 483.0 Pneumonia due to mycoplasma pneumoniae

ICD10


  • J13 Pneumonia due to Streptococcus pneumoniae
  • J18.9 Pneumonia, unspecified organism
  • J69.0 Pneumonitis due to inhalation of food and vomit
  • J95.851 Ventilator associated pneumonia
  • J14 Pneumonia due to Hemophilus influenzae
  • J15.0 Pneumonia due to Klebsiella pneumoniae
  • J15.211 Pneumonia due to methicillin suscep staph
  • J15.7 Pneumonia due to Mycoplasma pneumoniae

SNOMED


  • 233604007 Pneumonia (disorder)
  • 422588002 aspiration pneumonia (disorder)
  • 34020007 pneumonia due to Streptococcus (disorder)
  • 429271009 ventilator-acquired pneumonia (disorder)
  • 385093006 Community acquired pneumonia (disorder)
  • 408679000 healthcare associated pneumonia (disorder)
  • 441658007 pneumonia due to Staphylococcus aureus (disorder)
  • 46970008 Pneumonia due to Mycoplasma pneumoniae (disorder)
  • 64479007 Pneumonia due to Klebsiella pneumoniae
  • 70036007 Haemophilus influenzae pneumonia
Copyright © 2016 - 2017
Doctor123.org | Disclaimer